Trial · NCT04163874
Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
NCT04163874, Not applicable, Completed, McGill University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas. Trials, record NCT04163874. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04163874
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
- NCT number
- NCT04163874
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 36 participants, actual
- Lead sponsor
- McGill University
- Conditions
- Type 1 Diabetes, Type 1 Diabetes Mellitus, Hyperglycemia, Postprandial
- Interventions
- Fiasp, Pramlintide Acetate, Placebo, Artificial Pancreas
- First posted
- 2019-11-15
- Last updated
- 2022-10-10
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Each participant's time in target range | 12 days | Time in target range (3.9-10mmol/L) |
| Primary | Mean score of the Emotional Burden section of the Diabetes Distress Scale | 12 days | Average of all question's scores (from 1-6). Higher score means more emotional burden. |
| Secondary | Each participant's percentage of time of glucose levels spent between 3.9 and 7.8 mmol/L | 12 days | |
| Secondary | Each participant's percentage of time of glucose levels spent between 3.9 and 10 mmol/L | 12 days | |
| Secondary | Each participant's percentage of time of glucose levels spent below 3.9, 3.3, and 2.8 mmol/L | 12 days | |
| Secondary | Each participant's percentage of time of glucose levels spent above 7.8, 10, 13.9 and 16.7 mmol/L | 12 days | |
| Secondary | Each participant's mean glucose level | 12 days | |
| Secondary | Each participant's standard deviation of glucose levels as a measure of glucose variability | 12 days | |
| Secondary | Each participant's number of hypoglycemia events defined as at least 15 min below 3.0 mmol/L | 12 days | |
| Secondary | Each participant's number of Gastrointestinal symptoms | 12 days |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 38906614 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04163874
GET https://conductscience.org/api/trials/v1/NCT04163874/registered